Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $13.7 million.

  • Oncology Institute's Other Non-Current Liabilities rose 255719.84% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year increase of 255719.84%. This contributed to the annual value of $385000.0 for FY2024, which is 8750.81% down from last year.
  • Oncology Institute's Other Non-Current Liabilities amounted to $13.7 million in Q3 2025, which was up 255719.84% from $7.7 million recorded in Q2 2025.
  • Oncology Institute's 5-year Other Non-Current Liabilities high stood at $20.6 million for Q1 2022, and its period low was $385000.0 during Q4 2024.
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $4.0 million (2022), whereas its average is $6.1 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 9628.24% in 2023, then soared by 255719.84% in 2025.
  • Quarter analysis of 5 years shows Oncology Institute's Other Non-Current Liabilities stood at $6.9 million in 2021, then plummeted by 42.61% to $4.0 million in 2022, then decreased by 22.17% to $3.1 million in 2023, then crashed by 87.51% to $385000.0 in 2024, then surged by 3447.53% to $13.7 million in 2025.
  • Its Other Non-Current Liabilities stands at $13.7 million for Q3 2025, versus $7.7 million for Q2 2025 and $3.7 million for Q1 2025.